Nalaganje...
Pharmacogenomic Assessment of Patients with Colorectal Cancer and Potential Treatments
Evolving intensiveness of colorectal cancer (CRC) treatment, including chemotherapeutics and targeted agents associations, in adjuvant and metastatic CRC (MCRC) settings, increased overall survival (OS) with individual variability of toxicity. Pharmacogenomic guidelines recommended pre-treatment ide...
Shranjeno v:
| izdano v: | Pharmgenomics Pers Med |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7678498/ https://ncbi.nlm.nih.gov/pubmed/33235483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S253586 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|